Glyxambi 5 mg/1

Glyxambi 5 mg/1 tablets combine empagliflozin and linagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Glyxambi 5 mg/1 is used to help manage type 2 diabetes in adults. This combination medication works by addressing insulin resistance and improving glucose regulation. It is often prescribed alongside diet and exercise to support overall diabetes management.

Common effects of Glyxambi 5 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some users may also experience dizziness or headache. Individual responses can vary.

Glyxambi 5 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. Regular monitoring and consultation with a healthcare provider are recommended. Store at room temperature away from moisture and heat.

Glyxambi 5 mg/1 may interact with other medications, including insulin, sulfonylureas, and certain antibiotics. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider of all medications you are taking.